US tariffs could slash Fisher & Paykel Healthcare’s profit by $46m, analysts warn

US tariffs could slash Fisher & Paykel Healthcare’s profit by $46m, analysts warn
Fisher & Paykel could pass on potential tariff costs to customers, but those options will be limited by its market postition, Craigs analysts say. (Image: Fisher & Paykel Healthcare)
Rebecca Stevenson
US tariffs could mean a $46 million hit to Fisher & Paykel Healthcare’s profit in a worst-case scenario, analysts say. A research note by Craigs Investment Partners considered three potential tariff scenarios from the new US government under the leadership of President Donald Trump. About 40% of New Zealand Exchange-listed (NX) Fisher & Paykel Healthcare’s sales are in the US, or about 75% of its revenue. Trump has threatened to levy tariffs against imports from countries such as Mexico, Canada and China....

More Markets

NZ sharemarket continues momentum, Skellerup sees green
Markets Market Close

NZ sharemarket continues momentum, Skellerup sees green

 The Red Band gumboot-maker said it earned $54.5m after tax. 

Tom Raynel 21 Aug 2025
Xero board faces 'first strike' over CEO pay
Markets

Xero board faces 'first strike' over CEO pay

Xero investors fire warning shot at directors willing to pay big for talent.

Staff reporters 21 Aug 2025